Prostate cancer afflicts 16% American males according to The National Prostate Cancer Coalition. Depending on an individual’s risk factors, a doctor can recommend when patients should begin PSA screening for prostate cancer. According to the Harvard Medical School, even though PSA testing can help identify prostate cancer at an early stage, having an elevated PSA does not necessarily mean that a man has cancer. Some conditions including benign prostatic hyperplasia (BPH), or an enlarged prostate, and prostatitis, can raise PSA levels. In addition, studies indicate that about 70% to 80% of men with an elevated PSA who have a biopsy do not have cancer.
simMachines partnered with a bio-medical company to develop a next generation Prostate cancer test that is highly accurate. The only input required is a blood sample and the output will be a prediction: Aggressive cancer, Indolent cancer.
Detecting cancer from a blood sample reduces false positives and increases the Patient's chances of survival.